Scientists have identified a mechanism that switches on an extremely important process for the proper functioning and survival of our body’s cells. Specifically, the fast-track transportation pathway of ‘cargo’ to and from the surface of the cell.
Scientists discover switch mechanism for controlling
traffic in cells
Scientists have identified a mechanism that switches on an
extremely important process for the proper functioning and survival
of our body’s cells. Specifically, the fast-track transportation
pathway of ‘cargo’ to and from the surface of the cell. Defects in
this trafficking pathway can have severe consequences, leading to
numerous diseases such as high cholesterol, neuropathies, sterility
and complications in immune response. Understanding the mechanisms
underlying these disorders is crucial to developing possible
treatments and new therapeutic strategies.
Dr. Peter McPherson and Dr. Brigitte Ritter and their colleagues
have discovered how a molecule called Rab35, which acts as a switch
is turned on in order to activate the fast-track recycling pathway
– in which cargo that needs to be recycled back to the surface of
the cell is rapidly selected and transported. The new study,
published in the prestigious journal Molecular Cell, was
conducted at The Montreal Neurological Institute and Hospital – The
Neuro, McGill University.
“The cells that make up our bodies are like a busy city,” says
Dr. McPherson, neuroscientist at The Neuro and the co-principal
investigator for the study. “The cell surface is defined by a
membrane that separates its interior from the external world, like
the walls or borders of a city. Within this environment, there are
simultaneous trafficking pathways that transport vital nutrients,
receptors and other components required for cells to function,
within cargo vehicles called ‘vesicles.’ Like traffic in a city,
these ‘cargo’ vesicles travel at different speeds to numerous
destinations within the cell with different purposes. For
example, the receptors on the cell surface that bind to cholesterol
are on the fast track pathway, so that once they deliver the
cholesterol inside the cell, they move back to the surface quickly
so that they can pick up some more. It is therefore crucial to
understand the controls and switching mechanisms of trafficking
inside cells, as this system is of vital importance to the proper
functioning of the body.”
The Rab35 molecule is the trafficking switch for the fast-track
or high-priority recycling pathway signaling the quick return of
cargo to the cell surface membrane. It is known that Rab35 exists
in two forms, ‘on’ (GTP- bound) or off (GDP- bound). When Rab35 is
turned ‘on’, it allows the cargo to go back up to the cell surface.
What Dr. McPherson and Dr. Ritter and colleagues have discovered is
the switch that turns Rab35 on.
“In this study we identified that a particular region of the
vesicle-bound protein connecden, , called the DENN domain, is the
‘finger’ that flips the switch,” says Dr. Ritter. “The DENN domain
connects with the Rab35 molecule and through enzymatic activity
converts Rab35 from the inactive to the active form, in essence,
turning on the switch.”
DENN domains are found in multiple protein products encoded by
16 human genes. Mutations in the DENN domain cause humans diseases
such as sterility and Charcot-Marie-Tooth neuropathy, yet until now
the function of this common module has been unknown. The DENN
domain is evolutionarily ancient and bioinformatics studies suggest
that it is present in all eukaryotic, or multi-compartmental cells,
indicating that the DENN domain has mediated crucial functions
throughout evolution.
“If the finger or the switch itself is mutated or missing, cargo
can’t recycle, which has dire consequences,” adds Dr. McPherson.
“For example a very important cargo transported by this specific
fast track recycling pathway, controlled by Rab35 is the MHC class
I receptor involved in the immune system response. If a cell
becomes infected by a virus, the MHC receptor is loaded with
fragments of the virus that have infected the inside of a cell. The
MHC receptor needs to be taken back to the cell surface quickly so
that so that it can act as a signpost indicating to circulating
immune cells that this particular cell has been infected by a virus
and needs to be destroyed, preventing viral infection to other
cells.”
This critical new insight into the control mechanisms for the
cells’ trafficking system provide a deeper understanding of
diseases that result from complications in trafficking, as well as
provide new therapeutic targets for the development of
treatments.
This study was supported by the Fonds de la recherche en santé
du Québec (FRSQ), the Canadian Institutes of Health Research (CIHR)
and the National Institutes of Health (NIH).
About the Montreal Neurological Institute and
Hospital:
The Montreal Neurological Institute and Hospital - The Neuro is
a unique academic medical centre dedicated to neuroscience. The
Neuro is a research and teaching institute of McGill University and
forms the basis for the Neuroscience Mission of the McGill
University Health Centre. Founded in 1934 by the renowned Dr.
Wilder Penfield, The Neuro is recognized internationally for
integrating research, compassionate patient care and advanced
training, all key to advances in science and medicine. Neuro
researchers are world leaders in cellular and molecular
neuroscience, brain imaging, cognitive neuroscience and the study
and treatment of epilepsy, multiple sclerosis and neuromuscular
disorders. For more information, please visit www.mni.mcgill.ca.